Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyn van der Aa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 6, 2014
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccinesNadine van Montfoort, Evelyn van der Aa, Andrea M Woltman
Seminars in Cell & Developmental Biology|June 10, 2014
BDCA3(+)CLEC9A(+) human dendritic cell function and developmentEvelyn van der Aa, Nadine van Montfoort, Andrea M Woltman
Immunology and Cell Biology|January 25, 2018
Transcriptional patterns associated with BDCA3 expression on BDCA1<sup>+</sup> myeloid dendritic cellsEvelyn van der Aa, Paula J Biesta, Andrea M Woltman, et al.
Plos One|August 17, 2016
The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and FunctionEvelyn van der Aa, Sonja I Buschow, Paula J Biesta, et al.
European Journal of Immunology|January 24, 2015
BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-βEvelyn van der Aa, Lianne van de Laar, Harry L A Janssen, et al.
Journal of Virology|April 22, 2016
Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismNadine van Montfoort, Evelyn van der Aa, Aniek van den Bosch, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 6, 2014
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccinesNadine van Montfoort, Evelyn van der Aa, Andrea M Woltman
Seminars in Cell & Developmental Biology|June 10, 2014
BDCA3(+)CLEC9A(+) human dendritic cell function and developmentEvelyn van der Aa, Nadine van Montfoort, Andrea M Woltman
Immunology and Cell Biology|January 25, 2018
Transcriptional patterns associated with BDCA3 expression on BDCA1<sup>+</sup> myeloid dendritic cellsEvelyn van der Aa, Paula J Biesta, Andrea M Woltman, et al.
Plos One|August 17, 2016
The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and FunctionEvelyn van der Aa, Sonja I Buschow, Paula J Biesta, et al.
European Journal of Immunology|January 24, 2015
BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-βEvelyn van der Aa, Lianne van de Laar, Harry L A Janssen, et al.
Journal of Virology|April 22, 2016
Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismNadine van Montfoort, Evelyn van der Aa, Aniek van den Bosch, et al.
Pageof 1